Investing Profile

Michal Silverberg

VC
Managing Director at Novartis Venture Fund -NVF
Photo of Michal Silverberg, Managing Director at Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4974 CONNECTIONS
Hotmail Network
4974 CONNECTIONS
Columbia University in the City of New York Network
348 CONNECTIONS
Columbia University Network
252 CONNECTIONS
University of Haifa Network
16 CONNECTIONS
cb
Novartis Venture Fund Managing Director
$5.0M - $10.0M
$7.5M
6
$750M
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DJul 2026$67M
Series DMay 2025$40M
Series DAug 2023$75M
$250M
Co-investors: Simeon J. George (SR One), Matthew Foy (SROne), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Ran Nussbaum (Pontifax Venture Capital), Chandra Leo (HBM Partners AG)
Sidewinder Therapeutics
Series BApr 2026$140M
$140M
Co-investors: Daniel Estes (Frazier Life Sciences), John Hamer (Financial Services, Financial Technology, and Business Services)
Twentyeight-Seven Therapeutics
Series AMay 2019$15M
Series ASep 2018$65M
$80M
Co-investors: Kazumi Shiosaki (MPM Capital), Henrijette Richter (Sofinnova Partners)
VP Business Development and Operation MultiGene Vascular Systems (MGVS) LtdPresent
Manager Business Development HotmailPresent
Senior Director Business Development and New Product Commercialization Novo NordiskPresent
Managing Director HotmailPresent
Senior Partner Takeda Ventures, Inc.Present
University of Haifa BA Economics & Business
Columbia University MA Biotechnology
Columbia University in the City of New York MA Biotechnology
Sign in with Google →
Sign in with Google →